Female sex | 6 | (46.1%) |
Age (mean±SD) | 42.6 | (±13.0) |
Disease duration | 15.4 | (±10.4) |
Age at diagnosis (mean±SD) | 27.7 | (±13.1) |
Diagnosis <16 years old (A1) | 2 | (15.4%) |
Diagnosis 17–40 years old (A2) | 9 | (69.2%) |
Diagnosis >40 years old (A3) | 2 | (15.4%) |
Location | ||
Ileal only (L1) | 1 | (7.7%) |
Colonic only (L2) | 4 | (30.8%) |
Ileo-colonic (L3) | 8 | (61.5%) |
Concomitant upper GI disease (L4) | 2 | (15.4%) |
Perianal disease (p) | 2 | (15.4%) |
Behaviour | ||
Inflammatory (B1) | 9 | (69.2%) |
Stricturing (B2) | 2 | (15.4%) |
Penetrating (B3) | 2 | (15.4%) |
HBI (median, range) | 0 | (0–7) |
Active disease HBI ≥5 | 4 | (30.8%) |
Previous surgery | 8 | (61.5%) |
Medications | ||
Thiopurines | 7 | (53.8%) |
Biologics | 4 | (30.8%) |
Others | 3 | (23.1%) |
GI, gastrointestinal; HBI, Harvey Bradshaw Index.